Raghuraj Dangi
Raghuraj Dangi

Director - Life Sciences

About Raghuraj Dangi
Expertise
Life Sciences Pharma & Biotech MedTech Healthcare Digital Health Strategy & Analytics
Highlights
  • Consulting leader with broad experience in life sciences and healthcare.
  • Helps clients turn data and insight into decisive action.
  • Leads teams that deliver clear, practical outcomes.
  • Believes impact comes from focus and execution.
An accomplished consulting and analytics leader, Raghuraj Dangi brings more than 18 years of experience across the life sciences, pharma, medtech, and healthcare industries. At FutureBridge, he leads major client programs that transform data and insight into strategies for innovation and growth. Raghuraj’s expertise spans R&D analytics, competitive intelligence, market forecasting, and digital transformation. His experience leading large-scale consulting engagements helps organizations make data-driven decisions, optimize portfolios, and accelerate commercialization in complex markets. Recognized for his client-centric approach, analytical rigor, and ability to translate market intelligence into actionable strategies Raghuraj is Passionate about building high-performing teams to shape impact at the intersection of science, technology, and strategy.

Shaping Life Sciences

"Innovation in life sciences is no longer confined to the lab, but it’s driven by data, collaboration, and agility. I help clients turn scientific and market intelligence into strategies that create sustainable growth and lasting patient impact."

- Raghuraj Dangi

Publications and Videos

FutureBridge_what are biomaterials

What Are Biomaterials?

Executive Report

Biomaterials Insight | Strategic Primer What are biomaterials and why does material class selection matter so much in medical devices?...
FutureBridge_Biomaterials

How can your Biomaterial Innovation achieve commercial viability?

Executive Report

The Biomaterials Market Has Crossed $200 Billion. The Real Question Is: Which Innovations Will Actually Scale? Biomaterials are entering a...
FutureBridge_GLP-1 is creating a new skin baseline

The GLP-1 Body Reset: Why the Beauty Industry’s Window to Act Is Rapidly Closing

Article

100M+ Projected global GLP-1 users by 2030, from fewer than 15M today 22% Average body weight reduction on tirzepatide over...
FutureBridge_Surgical robot in operating room showing cost impact and ROI for MedTech healthcare systems

Do Surgical Robotics Reduce Healthcare Costs or Add to Them?

Article

No procurement committee, hospital CFO, or R&D leadership team has fully cracked this question yet. When a surgical robot rolls...

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.